Urology Database to Evaluate Clinical Information and Improve Patient Care.

This study is enrolling participants by invitation only.
William Beaumont Hospitals
Information provided by (Responsible Party):
Kenneth Peters, MD, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
First received: September 13, 2006
Last updated: May 12, 2014
Last verified: May 2014

The purpose of initiating the Urology Database is to evaluate the outcomes of urology procedures and medical management to enhance the care and treatment of urology patients.

Prostate Cancer
Interstitial Cystitis
Urinary Retention
Pelvic Organ Prolapse

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Urology Database for Outcomes Research

Resource links provided by NLM:

Further study details as provided by William Beaumont Hospitals:

Estimated Enrollment: 1000
Study Start Date: February 2004
Estimated Study Completion Date: February 2029
Estimated Primary Completion Date: February 2029 (Final data collection date for primary outcome measure)
Detailed Description:

The current study population will include all patients having had a radical prostatectomy for the treatment of prostate cancer, surgical prolapse repair as well as patients having had InterStim sacral nerve stimulator implantation. The database will house data extracted from the medical records. Patient demographics, and preoperative, intra-operative, postoperative, and follow-up clinical data will be collected.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Men and Women with conditions including radical prostatectomy, pelvic organ prolapse and neurostimulator implantation at William Beaumont Hospital


Inclusion Criteria:

All patients undergoing radical prostatectomy, pelvic organ prolapse repair and neurostimulator (Interstim) implantation at William Beaumont Hospital beginning January 1, 1998, as well as other urology patients as research questions are identified. Only patients who have accepted William Beaumont Hospital's Privacy Notices will be included in the database.

Exclusion Criteria:

Patients not acknowledging acceptance of William Beaumont Hospital's Privacy Notices.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00376298

United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
Kenneth Peters, MD
William Beaumont Hospitals
Principal Investigator: Kenneth Peters, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00376298     History of Changes
Other Study ID Numbers: 2004-050
Study First Received: September 13, 2006
Last Updated: May 12, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by William Beaumont Hospitals:
prostate cancer
interstitial cystitis

Additional relevant MeSH terms:
Cystitis, Interstitial
Pelvic Organ Prolapse
Urinary Retention
Pathological Conditions, Anatomical
Urinary Bladder Diseases
Urination Disorders
Urologic Diseases

ClinicalTrials.gov processed this record on March 30, 2015